JDRF Announces New Grant to Explore Methods to Relieve Diabetes Distress
JDRF, the world’s leading nonprofit funder of type 1 diabetes (T1D) research, announces a new grant to Albert Einstein College of Medicine and the Montefiore Health System. Led by endocrinologist Shivani Agarwal, MD, MPH, and psychologist Jeffrey Gonzalez, Ph.D., the study will use telemedicine to provide cognitive behavioral therapy to young adults with T1D to reduce distress related to T1D. diabetes.
JDRF is delighted to support the work of Drs. Agarwal and Gonzalez, and their team in exploring methods to alleviate diabetes-related distress in young adults. Psychosocial research is a priority for JDRF as we believe that avenues of supportive mental health care at all ages and stages of illness will best benefit the community as an aspect of management. “
Sanjoy Dutta, Ph.D., JDRF Vice President of Research
Primary research shows that young adults with T1D have high levels of diabetes-related distress and some of the highest blood sugar levels, as measured by HbA1c, among all age groups with T1D. To date, few studies have specifically targeted diabetes-related distress in young adults with the disease, and it is still unclear whether interventions can have a positive impact on blood sugar management in this population.
“We look forward to testing out-of-the-box care solutions that address the unmet psychological needs of young adults with T1D,” said Dr Agarwal, assistant professor of medicine and epidemiology and population health at Albert Einstein College of Medicine, clinical psychologist at Montefiore, and professor of psychology at the Ferkauf Graduate School of Psychology at Yeshiva University. “We are delighted to partner with JDRF to conduct this important study. “
This New York-based study will recruit 150 young adults nationwide, aged 18 to 30, to assess whether cognitive behavioral therapy delivered through telemedicine, as well as a continuous blood glucose monitor (CGM), will provide significant improvement in both diabetes-related distress and blood sugar control. , compared to CGM alone, which has become the current standard of care for T1D. Recruitment efforts will include young adults from Black and Hispanic non-Hispanic backgrounds who may be predominantly Spanish speaking to demonstrate the reach of the approach to underserved communities.
“After years of research documenting the negative impact of diabetes distress on quality of life and diabetes health outcomes, I am delighted to be part of a team that aims to do something about it. “said Dr. Gonzalez, professor of psychology. at the Ferkauf Graduate School of Psychology at Yeshiva University and the Departments of Medicine and Epidemiology and Population Health at the Albert Einstein College of Medicine. “This is a unique opportunity to rigorously test a short-term behavioral health solution for diabetes distress that, if successful, can be widely disseminated. “
If successful, this treatment, in addition to providing a scientific understanding of diabetes-related distress and blood sugar control in young adults, will support a new billable model of care for T1D that can be quickly integrated into practice. current clinic.